Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1988 Dec;95(4):1047–1056. doi: 10.1111/j.1476-5381.1988.tb11738.x

Fade and tachyphylaxis of gastric acid secretory response to pentagastrin in rat isolated gastric mucosa.

B H Hirst 1, J Holland 1, M E Parsons 1, C A Price 1
PMCID: PMC1854246  PMID: 3219480

Abstract

1. Gastric acid secretory responses to pentagastrin were characterized in the rat isolated gastric mucosa. In particular, the mechanisms underlying fade, declining response upon continued stimulation, and tachyphylaxis, progressively reduced responses upon repeated stimulation, were investigated. 2. Pentagastrin, 10(-9)-10(-7) M, resulted in concentration-related increases in acid secretion, with a mean maximum of 2.65 mumol cm-2 h-1 in response to pentagastrin, 10(-7) M. Higher concentrations of pentagastrin produced sub-maximal secretory rates; we define this as auto-inhibition. The responses to all concentrations of pentagastrin demonstrated fade. The rate of fade was correlated with the maximum acid secretory rate, declining at about 36% of the peak over the first 16 min. 3. The PO2, PCO2, [HCO3-], pH, [glucose], [lactate], [Na+] and [K+] did not decline during the fade of the acid secretory response to pentagastrin, 10(-7) M. Addition of a second aliquot of pentagastrin was not able to reverse fade, but these tissues were responsive to histamine. Replacement of the serosal solution, before addition of a second aliquot of pentagastrin, increased the acid response from 3% to 24% of the first response. 4. Serosal solution from donor tissues, allowed to respond to pentagastrin and then the acid secretion to fade, was able to stimulate secretion in fresh recipient tissues, although at lower rates. 5. Acid secretory responses to a second dose of pentagastrin were not significantly different, whether the tissues were previously unstimulated, or stimulated with pentagastrin washed out after attaining its peak secretory response (after 10-20 min). The second response was significantly reduced if the first response was allowed to fade with the pentagastrin in contact for 100 min; i.e. fade significantly influenced the extent of tachyphylaxis. 6. Proglumide, 10(-2) M, a gastrin receptor antagonist, and omeprazole, 10(-5) M, an inhibitor of the gastric (H+ + K+)-ATPase, both inhibited pentagastrin-stimulated acid secretion to similar extents. The second response to pentagastrin after pentagastrin alone, or pentagastrin plus omeprazole were both reduced compared to responses after no stimulation or omeprazole alone, respectively. After pentagastrin plus proglumide, the second response to pentagastrin was not lower than after proglumide alone. Proglumide, but not omeprazole, therefore, prevented pentagastrin tachyphylaxis. 7. It is concluded that gastrin fade and tachyphylaxis are related phenomena. Part of the fade may be due to release of an inhibitor(s). The major proportion of tachyphylaxis is a result of specific interaction of gastrin with its receptors.

Full text

PDF
1047

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albinus M., Blair E. L., Hirst B. H., Reed J. D., Schally A. V., Shaw B. The effects of somatostatin and metiamide on tachyphylaxis of pentagastrin stimulated gastric acid and pepsin secretion in the conscious cat. J Physiol. 1977 Apr;266(3):801–817. doi: 10.1113/jphysiol.1977.sp011794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Black J. W., Shankley N. P. The isolated stomach preparation of the mouse: a physiological unit for pharmacological analysis. Br J Pharmacol. 1985 Nov;86(3):571–579. doi: 10.1111/j.1476-5381.1985.tb08933.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boughton-Smith N. K., Whittle B. J. The gastric antisecretory actions of prostaglandin E2 and stable prostacyclin analogues against different secretagogues in perfused whole-stomachs of rat or mouse in vitro. Br J Pharmacol. 1981 Feb;72(2):291–298. doi: 10.1111/j.1476-5381.1981.tb09128.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bunce K. T., Parsons M. E., Rollings N. A. The effect of metiamide on acid secretion stimulated by gastrin, acetylcholine and dibutyryl cyclic adenosine 3',5'-monophosphate in the isolated whole stomach of the rat. Br J Pharmacol. 1976 Sep;58(1):149–156. doi: 10.1111/j.1476-5381.1976.tb07704.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Davison J. S., Najafi-Farashah A. The effect of dibutyryl cyclic guanosine monophosphate, a competitive antagonist to cholecystokinin-pancreozymin, on gastric acid secretion in the isolated mouse stomach. Life Sci. 1982 Jul 26;31(4):355–361. doi: 10.1016/0024-3205(82)90415-5. [DOI] [PubMed] [Google Scholar]
  6. Emås S., Grossman M. I. Comparison of gastric secretion in conscious dogs and cats. Gastroenterology. 1967 Jan;52(1):29–34. [PubMed] [Google Scholar]
  7. Emås S., Nylander G., Wallin B. Comparison of the dose-response curves for acid output to pentagastrin determined by two techniques in chronic gastric fistula rats. Digestion. 1981;22(2):94–100. doi: 10.1159/000198602. [DOI] [PubMed] [Google Scholar]
  8. Forte J. G., Forte T. M., Machen T. E. Histamine-stimulated hydrogen ion secretion by in vitro piglet gastric mucosa. J Physiol. 1975 Jan;244(1):15–31. doi: 10.1113/jphysiol.1975.sp010782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. GILLESPIE I. E., GROSSMAN M. I. Inhibition of gastric secretion by extracts containing gastrin. Gastroenterology. 1963 Mar;44:301–310. [PubMed] [Google Scholar]
  10. Hirschowitz B. I., Sachs G. Pentagastrin in the gastric fistula dog. Gastroenterology. 1969 Mar;56(3):456–467. [PubMed] [Google Scholar]
  11. Hirst B. H., Holland J., Marr A. P., Parsons M. E., Sanders D. J. Comparison of effect of peptide length and sulphation on acid secretory potency of gastrin in the cat in vivo and in vitro. J Physiol. 1984 Dec;357:441–452. doi: 10.1113/jphysiol.1984.sp015510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hirst B. H. Investigation of mechanism of fade of gastrin-stimulated gastric acid secretion in the cat. J Physiol. 1988 Jan;395:319–331. doi: 10.1113/jphysiol.1988.sp016921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hirst B. H., Labib L. A., Reed J. D. Characteristics and tachyphylaxis of gastrin-stimulated gastric acid secretion in the cat. J Physiol. 1978 Mar;276:1–11. doi: 10.1113/jphysiol.1978.sp012216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hirst B. H., Reed J. D., Lund P. K., Sanders D. J. Sensitivity of parietal cells to gastrin in the cat: comparison with man and dog. Digestion. 1980;20(5):300–306. doi: 10.1159/000198451. [DOI] [PubMed] [Google Scholar]
  15. Izzat A., Waton N. G. Release of 5-hydroxytryptamine by pentagastrin and its role in the 'fade' of stimulated gastric secretion in cats. J Physiol. 1987 Feb;383:499–507. doi: 10.1113/jphysiol.1987.sp016424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kasbekar D. K., Ridley H. A., Forte J. G. Pentagastrin and acetylcholine relation to histamine in H+ secretion by gastric mucosa. Am J Physiol. 1969 Apr;216(4):961–967. doi: 10.1152/ajplegacy.1969.216.4.961. [DOI] [PubMed] [Google Scholar]
  17. Kasbekar D. K. Secretagogue-induced tachyphylaxis of gastric H + secretion and its reversal. Am J Physiol. 1972 Aug;223(2):294–299. doi: 10.1152/ajplegacy.1972.223.2.294. [DOI] [PubMed] [Google Scholar]
  18. Kuo Y. J., Shanbour L. L. Acid secretion by isolated canine gastric mucosa. J Physiol. 1978 Dec;285:325–340. doi: 10.1113/jphysiol.1978.sp012574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lotti V. J., Chang R. S., Kling P. J., Cerino D. J. Evidence that cholecystokinin octapeptide (CCK-8) acts as a potent, full agonist on gastrin receptors for acid secretion in the isolated mouse stomach: lack of antagonism by the specific CCK antagonist asperlicin. Digestion. 1986;35(3):170–174. doi: 10.1159/000199363. [DOI] [PubMed] [Google Scholar]
  20. Magous R., Bali J. P. Evidence that proglumide and benzotript antagonize secretagogue stimulation of isolated gastric parietal cells. Regul Pept. 1983 Nov;7(3):233–241. doi: 10.1016/0167-0115(83)90016-2. [DOI] [PubMed] [Google Scholar]
  21. Main I. H., Pearce J. B. Increased histamine-output from the isolated gastric mucosa of the rat in response to pentagastrin and methacholine. Br J Pharmacol. 1982 May;76(1):51–59. doi: 10.1111/j.1476-5381.1982.tb09190.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Pilot M. A. Acid secretion from the completely isolated blood perfused canine stomach. J Physiol. 1979 Nov;296:113–123. doi: 10.1113/jphysiol.1979.sp012994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Prugh M. F., Schorr B. A., Vlahcevic Z. R., Makhlouf G. M. Intravenous pentagastrin as a partial agonist of gastric secretion in man: evidence in favor of the existence of hormonal inhibitory sites. Gastroenterology. 1975 Jan;68(1):45–49. [PubMed] [Google Scholar]
  24. Reed J. D., Smy J. R. Effects of isopropylnoradrenaline on tachyphylaxis of gastrin stimulated gastric acid secretion and mucosal blood flow in the anaesthetized cat. J Physiol. 1976 Jan;254(1):153–168. doi: 10.1113/jphysiol.1976.sp011226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Reeves J. J., Stables R. Effects of indomethacin, piroxicam and selected prostanoids on gastric acid secretion by the rat isolated gastric mucosa. Br J Pharmacol. 1985 Nov;86(3):677–684. doi: 10.1111/j.1476-5381.1985.tb08945.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Soll A. H., Amirian D. A., Thomas L. P., Park J., Elashoff J. D., Beaven M. A., Yamada T. Gastrin receptors on nonparietal cells isolated from canine fundic mucosa. Am J Physiol. 1984 Dec;247(6 Pt 1):G715–G723. doi: 10.1152/ajpgi.1984.247.6.G715. [DOI] [PubMed] [Google Scholar]
  27. Soll A. H., Amirian D. A., Thomas L. P., Reedy T. J., Elashoff J. D. Gastrin receptors on isolated canine parietal cells. J Clin Invest. 1984 May;73(5):1434–1447. doi: 10.1172/JCI111348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Soll A. H., Yamada T., Park J., Thomas L. P. Release of somatostatinlike immunoreactivity from canine fundic mucosal cells in primary culture. Am J Physiol. 1984 Nov;247(5 Pt 1):G558–G566. doi: 10.1152/ajpgi.1984.247.5.G558. [DOI] [PubMed] [Google Scholar]
  29. Spencer J. The rat isolated stomach sheet; an in vitro model for the study of the physiology and pharmacology of gastric acid secretion. J Pharmacol Methods. 1982 Nov;8(3):197–212. doi: 10.1016/0160-5402(82)90074-2. [DOI] [PubMed] [Google Scholar]
  30. Swillens S., Dumont J. E. The mobile receptor hypothesis in hormone action: a general model accounting for desensitization. J Cyclic Nucleotide Res. 1977 Feb;3(1):1–10. [PubMed] [Google Scholar]
  31. Takeuchi K., Speir G. R., Johnson L. R. Mucosal gastrin receptor. II. Physical characteristics of binding. Am J Physiol. 1979 Sep;237(3):E295–E300. doi: 10.1152/ajpendo.1979.237.3.E295. [DOI] [PubMed] [Google Scholar]
  32. Takeuchi K., Speir G. R., Johnson L. R. Mucosal gastrin receptor. III. Regulation by gastrin. Am J Physiol. 1980 Feb;238(2):G135–G140. doi: 10.1152/ajpgi.1980.238.2.G135. [DOI] [PubMed] [Google Scholar]
  33. Wallmark B., Lorentzon P., Larsson H. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro. Scand J Gastroenterol Suppl. 1985;108:37–51. [PubMed] [Google Scholar]
  34. Yates J. C., Schofield B., Roth S. H. Acid secretion and motility of isolated mammalian gastric mucosa and attached muscularis externa. Am J Physiol. 1978 Mar;234(3):E319–E326. doi: 10.1152/ajpendo.1978.234.3.E319. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES